- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who live with this condition in the Long-Term Care (LTC) setting. This information is intended to help provide a better understanding of the implications of this disorder that are associated with it in the LTC environment including prevalence, medication use, costs of care and the challenges associated with antipsychotic use. It also describes the diagnostic criteria for AAD and explores the potential pathobiological correlations in AAD. Objectives:
- Learn about agitation associated with Alzheimer’s Dementia (AAD) as a highly prevalent disorder that is present in all stages and severities for those with Alzheimer’s dementia
- Gain understanding about the potential pathobiological elements, and the associated neurotransmitters implicated with AAD
- Review information related to patient and care-giver burden as well as the healthcare utilization and costs associated with AAD li>Consider the class of antipsychotics and the challenges associated with using this class of medications in the Long-Term Care setting.
Featuring
Justin Rash, PharmD, BCGP (OPDC)
Senior Medical Science Liaison
Speaker Justin Rash, PharmD, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
Registration
Related Resources
-
Practical Application of Wellness Strategies for Individuals in Underserved Communities with Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
On-Demand Webinar July 12, 2024Approximately 50 million United States adults are living with a mental illness, with 21 million having depression and 13 million with post-traumatic stress disorder.1-4 Minority individuals are among these prevalence…
-
Talking Points (Part I): Primary Care on PTSD – David Lewis
Podcast July 10, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Post-Traumatic Stress Disorder (PTSD) with special guest, David E….
-
Primary Care PTSD Screen For DSM-5 (PC-PTSD-5)
Downloadable Resource June 27, 2024The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screen designed to identify individuals with probable PTSD in primary care settings. The measure begins with an item which assesses lifetime…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: